Literature DB >> 35865229

Transcatheter closure of residual Gerbode defect after aortic valve replacement surgery.

Mehdi Slim1, Nouha Mekki1, Sami Ouannes1, Elies Neffati1.   

Abstract

A 42-year-old man with a history of surgically repaired coarctation of the aorta presented with a refractory right heart failure. Echocardiography revealed a calcified bicuspid aortic valve both regurgitant and stenotic and a defect within the membranous septum with left to right shunt from the left ventricle (LV) to the right atrium. The patient was referred to surgery for an aortic valve replacement and closure with patch repair of the Gerbode type defect. Post-operative course was complicated by refractory heart failure with a persistent left to right shunt through the defect due to loose sutures. Taking into account the high surgical risk, percutaneous closure of the defect was decided. An Amplatzer Duct Occluder (St Jude Medical, USA) I device was successfully released within the defect. The patient was completely asymptomatic on follow-up.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Year:  2022        PMID: 35865229      PMCID: PMC9295689          DOI: 10.1093/ehjcr/ytac283

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


A 42-year-old man with a history of surgically repaired coarctation of the aorta at the age of 25 was referred to our department for refractory right heart failure (RHF). Five months before admission, he presented with fever, abdominal pain but with negative infectious investigations. He was started on a 2-week intravenous antibiotic therapy with a good clinical course. Physical examination revealed severe signs of RHF and a loud 4/6 holosystolic murmur. Transthoracic echocardiography (TTE) revealed a calcified bicuspid aortic valve both regurgitant and stenotic. A 7 mm defect within the perimembranous ventricular septum was noted with a L–R shunting, but the jet was directed into the right atrium (, see Supplementary material online, ). (A and B) Transthoracic echocardiography locating the defect above the tricuspid valve (A) and the left to right shunt through the defect in colour mode (B). Four chamber view in cardiac computed tomography scan (C) and cardiac magnetic resonance imaging (D) showing the communication between the left ventricle and right atrium. (E) 3D transoesophageal echocardiography atrial view showing the Gerbode defect (arrow). (F) Left ventricle angiography with a pigtail introduced through the defect showing the left to right shunt from the left ventricle to the right atrium (arrow). Fluoroscopic (G) and echocardiographic guidance (H) of the position before device release. (I and J) Final result. Cardiac computed tomography (CT) scan confirmed the presence of the defect (). Cardiac magnetic resonance imaging (MRI) showed a Type A Gerbode defect (GD) (, see Supplementary material online, ). The patient was referred to surgery for an aortic valve replacement with a mechanical prosthesis and patch repair of the GD. A few days post-operative, the patient presented with congestive HF. The TTE confirmed the presence of a persisting GD due to loose sutures. Taking into account the high surgical risk, percutaneous closure of the defect was decided. Under general anaesthesia, we first proceeded with a 3D transoesophageal echocardiography study (, see Supplementary material online, ).[1] Left ventricle angiography was first performed (, see Supplementary material online, ). A 12/10 ADO I device was successfully released within the defect after confirming the absence of impingement of the aortic valve prosthesis or the TV leaflets and no relevant residual shunt (, see Supplementary material online, ).[2] The procedure was uneventful. After 12 months of follow-up, he was asymptomatic. The TTE showed trivial residual shunt and a moderate intraprothetic regurgitation (see Supplementary material online, ). Click here for additional data file.
  1 in total

Review 1.  Gerbode defect: Another nail for the 3D transesophagel echo hammer?

Authors:  Tuncay Taskesen; Andrew Fred Prouse; Steven Lewis Goldberg; Edward Allen Gill
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-14       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.